Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis.
Vélez ID, Gilchrist K, Martínez S, Ramírez-Pineda JR, Ashman JA, Alves FP, Coler RN, Bogatzki LY, Kahn SJ, Beckmann AM, Cowgill KD, Reed SG, Piazza FM.
Vélez ID, et al. Among authors: bogatzki ly.
Vaccine. 2009 Dec 11;28(2):329-37. doi: 10.1016/j.vaccine.2009.10.045. Epub 2009 Oct 30.
Vaccine. 2009.
PMID: 19879995
Clinical Trial.